Show simple item record

dc.contributor.authorJones, PB
dc.contributor.authorLopez-Morinigo, Javier-David
dc.contributor.authorAjnakina, Olesja
dc.contributor.authorWiffen, Benjamin
dc.contributor.authorMorgan, Kevin
dc.contributor.authorDoody, Gillian
dc.contributor.authorAyesa-Arriola, Rosa
dc.contributor.authorDi Forti, Marta
dc.contributor.authorCanal-Rivero, Manuel
dc.contributor.authorCrespo-Facorro, Benedicto
dc.contributor.authorMurray, Robin
dc.contributor.authorDazzan, Paola
dc.contributor.authorMorgan, Craig
dc.contributor.authorDutta, Rina
dc.contributor.authorDavid, Anthony
dc.date.accessioned2019-03-29T10:59:54Z
dc.date.available2019-03-29T10:59:54Z
dc.date.issued2019-02
dc.identifier.issn0920-9964
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/290963
dc.description.abstractABSTRACT Background: The role of insight dimensions – illness recognition (IR), symptoms relabelling (SR), treatment compliance (TC) - in suicide risk in first-episode psychosis (FEP) remains unclear. Method: The AESOP (n=181) and GAP (n=112) FEP cohorts were followed-up over 10- and 5 years. Survival analysis modelled time to first suicidal event in relation to baseline scores on the Schedule for the Assessment of Insight, whilst adjusting for demographic, clinical, psychopathological and neuropsychological variables.
dc.description.sponsorshipThis work represents independent research which was supported by the UK Medical Research Council (grant number G0500817) and partly-funded by the UK Department of Health via the National Institute for Health Research (NIHR) Specialist Biomedical Research Centre for Mental Health award to the South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry, Psychology and Neuroscience at Kings College London. JDLM was funded by the British Medical Association via the Margaret Temple Research Award for Schizophrenia. PBJ received funding support from the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research & Care (CLAHRC), East of England. RMM was supported by the Medical Research Council and Lord Leverhulme Trust. CM is funded by grants from the Medical Research Council (grant number MR/P025927/1) and EU (grant number ERC Ref: 648837 REACH). RD is funded by a Clinician Scientist Fellowship awarded by the Academy of Medical Sciences in partnership with The Health Foundation. ASD is supported by National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and Kings College London.
dc.publisherElsevier
dc.titleInsight and risk of suicidal behaviour in two first-episode psychosis cohorts: effects of previous suicide attempts and depression
dc.typeArticle
prism.endingPage89
prism.publicationDate2019
prism.publicationNameSchizophrenia Research
prism.startingPage80
prism.volume204
dc.identifier.doi10.17863/CAM.38142
dcterms.dateAccepted2018-09-15
rioxxterms.versionofrecord10.1016/j.schres.2018.09.016
rioxxterms.versionAM
rioxxterms.licenseref.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
rioxxterms.licenseref.startdate2019-02
dc.identifier.eissn1573-2509
rioxxterms.typeJournal Article/Review
cam.issuedOnline2018-09-22
rioxxterms.freetoread.startdate2019-09-22


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record